FDA Alerts Patients and Health Care Professionals to Nitrosamine Impurity Findings in Certain Metformin Extended-Release Products

SILVER SPRING, Md., May 28, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration is announcing today that agency laboratory testing has revealed levels of the nitrosamine impurity N-Nitrosodimethylamine (NDMA) above the agency's acceptable intake limit in several lots of the...

from PR Newswire: https://ift.tt/2MahfNK